» Articles » PMID: 38005904

Genomic Markers Associated with Cytomegalovirus DNAemia in Kidney Transplant Recipients

Overview
Journal Viruses
Publisher MDPI
Specialty Microbiology
Date 2023 Nov 25
PMID 38005904
Authors
Affiliations
Soon will be listed here.
Abstract

Human cytomegalovirus (CMV) is a major pathogen after solid organ transplantation, leading to high morbidity and mortality. Transplantation from a CMV-seropositive donor to a CMV-seronegative recipient (D+/R-) is associated with high risk of CMV disease. However, that risk is not uniform, suggesting a role for host factors in immune control of CMV. To identify host genetic factors that control CMV DNAemia post transplantation, we performed a whole-exome association study in two cohorts of D+/R- kidney transplant recipients. Quantitative CMV DNA was measured for at least one year following transplantation. Several CMV-protective single-nucleotide polymorphisms (SNPs) were identified in the first cohort (72 patients) but were not reproducible in the second cohort (126 patients). A meta-analysis of both cohorts revealed several SNPs that were significantly associated with protection from CMV DNAemia. The copy number variation of several genes was significantly different between recipients with and without CMV DNAemia. Amongst patients with CMV DNAemia in the second cohort, several variants of interest ( < 5 × 10), the most common of which was NLRC5, were associated with peak viral load. We provide new predictive genetic markers for protection of CMV DNAemia. These markers should be validated in larger cohorts.

Citing Articles

Real-world safety of maribavir: a retrospective study based on signal detection in the FDA adverse event reporting system.

Gong Q, Zhang L, Wu H, Miao Y, Huang L, Yin C Int J Clin Pharm. 2025; .

PMID: 39821007 DOI: 10.1007/s11096-025-01869-4.

References
1.
Helantera I, Teppo A, Koskinen P, Tornroth T, Gronhagen-Riska C, Lautenschlager I . Increased urinary excretion of transforming growth factor-beta(1) in renal transplant recipients during cytomegalovirus infection. Transpl Immunol. 2006; 15(3):217-21. DOI: 10.1016/j.trim.2005.11.001. View

2.
Helantera I, Loginov R, Koskinen P, Tornroth T, Gronhagen-Riska C, Lautenschlager I . Persistent cytomegalovirus infection is associated with increased expression of TGF-beta1, PDGF-AA and ICAM-1 and arterial intimal thickening in kidney allografts. Nephrol Dial Transplant. 2005; 20(4):790-6. DOI: 10.1093/ndt/gfh714. View

3.
Duchowny K, Noppert G . The Association Between Cytomegalovirus and Disability by Race/Ethnicity and Sex: Results From the Health and Retirement Study. Am J Epidemiol. 2021; 190(11):2314-2322. PMC: 8799899. DOI: 10.1093/aje/kwab152. View

4.
Lek M, Karczewski K, Minikel E, Samocha K, Banks E, Fennell T . Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016; 536(7616):285-91. PMC: 5018207. DOI: 10.1038/nature19057. View

5.
Wang K, Li M, Hakonarson H . ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010; 38(16):e164. PMC: 2938201. DOI: 10.1093/nar/gkq603. View